Medicine and Health. 1990. A shot in the arm for vaccine advocates. Perspectives. July 30. Washington, D.C.
MedImmune, Inc. 1991. Annual Report. Gaithersburg, Maryland.
Merck & Co., Inc. 1991a. Annual Report. Rahway, New Jersey.
Merck & Co., Inc. 1991b. Form 10-K. Washington, D.C.: Securities and Exchange Commission.
National Institute of Allergy and Infectious Diseases. 1992a. Report of the Task Force on Microbiology and Infectious Disease. April. Bethesda, Maryland.
National Institute of Allergy and Infectious Diseases 1992b. The Jordan Report. Bethesda, Maryland.
National Vaccine Advisory Committee. 1992. Access to Childhood Immunizations: Recommendations and Strategies for Action. April. Rockville Maryland.
North American Vaccine. 1991. Annual Report. Beltsville, Maryland.
Office of Technology Assessment. 1979. A Review of Selected Federal Vaccine and Immunization Policies. September. Washington, D.C.
Pan American Health Organization. Undated. General information. Washington, D.C.
Pan American Health Organization. 1991. Regional System for Vaccines (SIREVA) Feasibility Study. Washington, D.C.
Pharmaceutical Manufacturers Association. 1990. New Medicines in Development for Children. Fall. Washington, D.C.
Poore P. 1992. Availability of quality vaccines: Policies of a nongovernmental organization. Vaccine 10:958–960.
Rockefeller Foundation. 1991. Annual Report. New York, New York.
Rotary Foundation of Rotary International. Undated. Polio Plus Evanston, Illinois.
SmithKline Beecham. 1991. Annual Report. Philadelphia.
Task Force for Child Survival and Development. Undated. General information. Atlanta.
UNICEF. 1991. Executive Board Action Item: Establishment of a Vaccine Independence Initiative. March 12. New York, New York.
UNICEF. 1992. Vaccine Independence Initiative. Project Proposal for Funding by Interested Donors. July 13. New York, New York.
United Nations Development Program. 1992. New York, New York.
UNIVAX Biologics, Inc. 1992. Common Stock Prospectus. February 4. Rockville, Maryland.
U.S. Agency for International Development. 1992. Overview of Activities Supportive of the Children's Vaccine Initiative. Washington, D.C.
U.S. Department of Defense. Army. Office of the Surgeon General. Health Measures and Immunizations, Preventive Medicine in World War 11. Washington, D.C.
U.S. Department of Health and Human Services. 1992. Report on NVPO Expenditures for Acellular Pertussis Vaccine Research and other Activities. January. Washington, D.C.
World Bank. 1992. Annual Report. Washington, D.C.
World Health Organization. 1991. Programme for Vaccine Development: a WHO/UNDP Partnership. December. Geneva.
World Health Organization. 1992. EPI for the 1990s. Geneva.
World Health Organization/Children's Vaccine Initiative. 1993. Global Investment in Children's Vaccine Research and Development: Results of a Survey. April. Geneva.
World Health Organization/Children's Vaccine Initiative. 1992a. Core Budget and Programme of Work for 1992 and 1993. October. Geneva.
World Health Organization/Children's Vaccine Initiative. 1992b. Report of the Task Force on Situation Analysis. November. Geneva.